Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Ahead of Print

Neurofibromatosis and breast cancer: Do we need to revise the mammographic screening schedule in patients of neurofibromatosis?

1 Department of Pathology, PGIMER, Chandigarh, India
2 Department of Radiodiagnosis and Imaging, PGIMER, Chandigarh, India
3 Department of Pediatrics, Grant Medical College, Mumbai, Maharashtra, India
4 Department of Pediatrics, Pt. JNM Medical College, Raipur, Chhattisgarh, India
5 Department of Pathology, Pushpanjali Crosslay Hospital, New Delhi, India
6 Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Correspondence Address:
Dinesh Pradhan,
PGIMER, Sector 12, Chandigarh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Neurofibromatosis type 1 (NF-1) is a neurocutaneous syndrome with autosomal dominant mode of inheritance and has a high propensity to develop benign and malignant nervous system tumors. Although uncommon, case reports describing the association of NF-1 and breast cancer are available in the literature. We illustrate one such case of NF-1, with no family history of the disorder and presenting with multifocal invasive carcinoma of the right breast, in an attempt to describe the association between these two entities. We also attempt to extensively review the current literature on the subject. Since patients with NF-1 are at an increased risk of developing breast cancer, we recommend strict adherence to careful clinical breast examination and annual screening mammographic examination starting at 40 years of age in all patients of NF-1.

Print this article
  Search Pubmed for
    -  Pradhan D
    -  Kaur N
    -  Gami A
    -  Hura KS
    -  Garg G
    -  Mohanty SK
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded4    

Recommend this journal